Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Joysticks recalled after power wheelchairs move on their own, injuring a patient
The U.S. Food and Drug Administration announced a recall of Mo-Vis BVBA joysticks after a faulty firmware version was linked to the malfunction. Users will need to have their devices upgraded.
FDA approves nasal spray for edema associated with congestive heart failure
The newly approved intranasal loop diuretic can also be used to treat edema in patients with liver and kidney disease.
Cardiologists lead charge for medical device approvals in Europe to be more rigorous
There is a belief among some clinicians that it is too easy for companies to gain CE mark approval for their medical devices. However, a new proposal from the European Society of Cardiology and other groups could help change that.
Medline recalls surgical kits due to safety concern with Medtronic catheters
The FDA is warning the public that certain Medline surgical kits may contain catheters that have been linked to 41 customer complaints and three serious injuries.
COVID-induced neuroinflammation can last 2 years or longer, according to new PET data
These findings are important to consider with regard to patients’ long-term health, as chronic inflammation has been implicated in cognitive decline.

The approval includes patients as young as three months old.

The study's authors examined data from more than 21,000 participants.

This new measurement, researchers explained, can help clinicians target high-risk patients with more aggressive treatments.

The SGLT2 inhibitor was approved for this new indication based on results from the EMPEROR-Reduced trial.

Aortic stenosis is only seen in 1% of younger STEMI patients, but it becomes more and more common as patients get older.

The procedure, like the hospital's first 99 TAVR cases, was a success.

The full Arctic Front line is now approved as a first-line treatment for heart rhythm issues.

Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.